Pain Management Devices Market Size to Envision USD 19.10 Billion by 2034

The pain management devices market size is calculated at USD 8.41 billion in 2025 and is expected to reach around USD 19.1 billion by 2034, growing at a CAGR of 9.54% for the forecasted period.

Ottawa, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The global pain management devices market size was valued at USD 7.68 billion in 2024 and is predicted to hit around USD 19.1 billion by 2034, rising at a 9.54% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.

The global pain management devices market is driven by growing innovation and applications, along with the expanding healthcare sector.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5742

Key Takeaways

North America held a major revenue of 48% share of the market in 2024.
Asia-Pacific is expected to witness the fastest growth in the pain management devices market during the forecast period.
By product, the neurostimulation segment dominated the market in 2024.
By product, the radiofrequency ablation segment is expected to be the fastest growing during the forecast period.
By application, the neuropathic pain segment dominated the market in 2024.
By application, the cancer segment is expected to be the fastest growing during the forecast period.
By end-use, the hospitals & clinics segment dominated the market in 2024.
By end-use, the physiotherapy centers segment is expected to be the fastest growing during the forecast period

What are the Pain Management Devices?

The pain management devices market is expanding due to the growth in the non-invasive devices, neuromodulation applications, and increasing demand for wearable medical devices, along with the integration of smart technologies like AI or IOT for personalized therapies. The pain management devices refer to the medical tools used to alleviate or control acute or chronic pain. They include various technologies such as far infrared radiation (FIR) devices, wearable pain relief devices, transcutaneous electrical nerve stimulation, and advanced therapeutic tools.

What are the Major Growth Drivers Pain Management Devices Market?

The growing opioid crisis is the major driver that is increasing the use of pain management devices to reduce the risk of opioid addiction or overdose. This, in turn, is increasing the demand and use of safer alternatives such as neurosimulation or radiofrequency ablation to alleviate the pain. The other factors, such as increasing geriatric population, awareness, surgical procedures, demand for minimally invasive techniques, and technological advancements, are other market drivers.

Pain Management Devices Market Scope

Metric	Details
Market Size in 2025	USD 8.41 Billion
Projected Market Size in 2034	USD 19.1 Billion
CAGR (2025 - 2034)	9.54	%
Leading Region	North America share 48%
Market Segmentation	By Product, By Application, By End-Use, By Region
Top Key Players	Abbott Laboratories, Avanos Medical, Boston Scientific Corporation, Endo International plc, JOGO Health, LivaNova, NeuroOne Medical Technologies Corporation, Nevro Corp, Novartis AG, SPR Therapeutics, Inc., Stryker Corporation, Zynex, Inc

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Key Drifts in the Pain Management Devices Market?

The market has been expanding due to the growing funding to launch and enhance the development of various pain management devices.

In September 2025, Nalu Medical, Inc., which is a commercial-stage medical device company developing and commercializing neurostimulation solutions for patients with chronic intractable neuropathic pain was announced that it had received a commitment of up to $50 million in growth funding by Trinity Capital Inc.
In March 2025, a total of $13 million was secured in a Series A financing round by Nervonik. This funding will be used to expand the clinical trials, regulatory approvals, commercialization, and to enhance access to its innovative therapy as an alternative to traditional pain management.
In July 2025, a total of $56 million was received in Series D funding by Neuros Medical. This funding will be used to accelerate the U.S. launch of Altius®, which provides on-demand and non-opioid treatment for chronic post-amputation pain.
In January 2025, a successful closing of the $100 million financing was announced by Saluda Medical, Inc. This capital will be used to launch Evoke® System, which is a proprietary closed-loop, dose-control neuromodulation platform, as the first commercial application of the Company.

What is the Significant Challenge in the Pain Management Devices Market?

High costs act as a major challenge in the market, as it may limit the use of the pain management device. These devices require high upfront and maintenance costs, making them and their procedure costly, where limited reimbursement polices also make them expensive. Similarly, regulatory hurdles, patient compliance, and limited skilled personnel are other limitations of the market.

Regional Analysis

Why did North America Dominate the Pain Management Devices Market in 2024?

In 2024, North America captured the biggest revenue share of 48% in the market, due to growth in the patients with chronic pain, which increased the use of pain management devices as a non-opioid alternative. The presence of advanced healthcare infrastructure also increased the use of pain management devices by various hospitals and clinics, where growth in the healthcare investment increased their adoption rates. At the same time, companies also contributed to their growing R&D and launches. Moreover, the presence of reimbursement polices increased their use and made them more accessible. Thus, this, in turn, enhanced the market growth.

What Made Asia Pacific the Fastest-Growing in the Pain Management Devices Market in 2024?

Asia Pacific is expected to host the fastest growth in the market during the forecast period, due to expanding healthcare, which in turn increases the investments and adoption of advanced pain management technologies. The growing population is increasing the incidence of diseases such as arthritis, cancer, diabetes, etc, which is increasing their demand. At the same time, the growing awareness and increasing services such as rehabilitation and physiotherapy are also increasing their use and are driving the demand for wearable devices. Therefore, all these advancements with the support of government initiatives are promoting the market growth.

Download the single region market report @ https://www.towardshealthcare.com/price/5742

Segmental Insights

By product analysis

Why Did the Neurostimulation Segment Dominate in the Pain Management Devices Market in 2024?

By product, the neurostimulation segment held the largest share of the market in 2024, due to its high efficacy. It also helped in reducing adherence to the opioid pain management solutions. It was also used for the management of chronic pain.

By product, the radiofrequency ablation segment is expected to show the fastest growth rate during the predicted time. As it is a minimally invasive option, which provides quick recovery, its use is increasing, particularly for conditions such as arthritis and neck pain. It also provides long-term action and is affordable, which encourages its use.

By application analysis

What Made Neuropathic Pain the Dominant Segment in the Pain Management Devices Market in 2024?

By application, the neuropathic pain segment led the market in 2024, driven by its growing incidence. At the same time, growth in conditions like diabetes or cancer increased the demand for pain management devices for their chronic management. They were also used for the management of pain after surgeries.

By application, the cancer segment is expected to show the highest growth during the upcoming years. Their growing cases are increasing the demand for pain management devices. They are also being used as an alternative to opioids and are driving their innovations.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

By end-use analysis

How the Hospitals & Clinics Segment Dominated the Pain Management Devices Market in 2024?

By end-use, the hospitals & clinics segment held the dominating share of the market in 2024, as the provided advanced pain management devices. At the same time, due to the large volume of patients, their use increased. They were also used in various departments and after surgeries.

By end-use, the physiotherapy centers segment is expected to show the highest growth during the predicted time. The availability of advanced pain management technologies, devices, and specialties is attracting patients. Moreover, the high patient volume and surgeries are also increasing their use.

Recent Developments in the Pain Management Devices Market

In September 2025, an innovative cryoablation technology, that is the cryoXT™ device for the management of post-operative pain following amputation procedures, was launched by AtriCure Inc.
In April 2025, the Plum Solo^™ precision IV pump, which is a single-channel complement to the dual-channel Plum Duo^™, developed by ICU Medical Inc., was announced to have received 510(k) regulatory clearance from the U.S. FDA.
In February 2025, the BrainSense adaptive deep-brain stimulation (DBS) system and electrode identifier developed by Medtronic for the treatment of people with Parkinson’s disease were announced to have received U.S. FDA approval.

Browse More Insights of Towards Healthcare:

The global pediatric devices market is witnessing rapid growth, with revenues expected to reach hundreds of millions between 2025 and 2034.

The neurology devices market is also expanding significantly, valued at USD 15.98 billion in 2024 and rising to USD 17.28 billion in 2025. By 2034, the market is projected to reach approximately USD 34.76 billion, growing at a CAGR of 8.14% over the forecast period.

The nephrology devices market is on a steady upward trajectory, with a market size of USD 15.37 billion in 2024, increasing to USD 15.99 billion in 2025, and projected to reach USD 22.84 billion by 2034, at a CAGR of 4.04%.

Obstetrical devices market are similarly seeing gradual growth, valued at USD 8.52 billion in 2024 and expected to reach USD 8.83 billion in 2025. By 2034, the market is projected to grow to USD 12.18 billion, expanding at a CAGR of 3.64%.

The ENT devices market is projected to grow from USD 19.59 billion in 2024 to USD 20.88 billion in 2025, reaching around USD 36.71 billion by 2034, with a CAGR of 6.54%.

The medical device outsourcing market is experiencing strong expansion, with a market size of USD 160.3 billion in 2024, growing to USD 180.59 billion in 2025, and expected to reach USD 507.89 billion by 2034, at a robust CAGR of 12.65%.

Cardiovascular devices market are seeing consistent growth, rising from USD 78.13 billion in 2024 to USD 83.79 billion in 2025, and projected to reach USD 156.33 billion by 2034, at a CAGR of 7.24%.

The pacemaker market shows steady progress, growing from USD 5.45 billion in 2024 to USD 5.66 billion in 2025, with projections reaching USD 7.89 billion by 2034, at a CAGR of 3.75%.

Hernia mesh devices market are also on an upward trend, increasing from USD 5.63 billion in 2024 to USD 6.02 billion in 2025, and expected to reach USD 11.01 billion by 2034, expanding at a CAGR of 6.94%.

The life sciences enterprise storage market is growing steadily, with a market size of USD 2.71 billion in 2024, reaching USD 2.86 billion in 2025, and projected to hit USD 4.67 billion by 2034, at a CAGR of 5.65%.

Pain Management Devices Market Key Players List

Boston Scientific Corporation
Abbott Laboratories
Endo International plc
Avanos Medical
NeuroOne Medical Technologies Corporation
JOGO Health
Nevro Corp
Zynex, Inc
LivaNova
SPR Therapeutics, Inc.
Novartis AG
Stryker Corporation

Download the Competitive Landscape market report @ https://www.towardshealthcare.com/price/5742

Segments Covered in The Report

By Product

Neurostimulation
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Neurostimulators
- Others
Radiofrequency Ablation
- Electrical Stimulators
- TENS
- Others
Analgesic Infusion Pumps
- Intrathecal Infusion Pumps
- External Infusion Pumps

By Application

Neuropathic
Cancer
Facial & Migraine
Musculoskeletal
Trauma
Others

By End-Use

Hospitals & Clinics
Physiotherapy Centers
Rehabilitation Centers
Others

By Region

North America

U.S.
Canada

Asia Pacific

China
Japan
India
South Korea
Thailand

Europe

Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway

Latin America

Brazil Mexico
Argentina

Middle East and Africa (MEA)

South Africa
UAE
Saudi Arabia
Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5742

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.